scispace - formally typeset
L

Linda M. Mundy

Researcher at GlaxoSmithKline

Publications -  183
Citations -  6120

Linda M. Mundy is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Health care & Pneumonia. The author has an hindex of 39, co-authored 182 publications receiving 5840 citations. Previous affiliations of Linda M. Mundy include Saint Louis University & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

Community-Acquired Pneumonia

TL;DR: Pneumonia has been recognized as a common and potentially lethal condition for nearly two centuries as discussed by the authors, and community-acquired pneumonia (as distinguished from that acquired nosocomially or in a nursing home) continues to be a very serious illness.
Journal ArticleDOI

Environmental Control to Reduce Transmission of Clostridium difficile

TL;DR: Unbuffered 1:10 hypochlorite solution is effective in decreasing patients' risk of developing CDAD in areas where CDAD is highly endemic, and presumed mechanisms include reducing the environmental burden and the potential for C. difficile transmission among susceptible patients.
Journal ArticleDOI

Sex differences in nevirapine rash.

TL;DR: In women of reproductive age for whom contraception may occur, nevirapine remains the NNRTI of choice, and women had a 7-fold increase in risk for severe rash and were 3.5 times more likely to discontinue ne virapine therapy.
Journal ArticleDOI

Community-acquired pneumonia: impact of immune status.

TL;DR: This cross-sectional and prospective one year study evaluated adults admitted to an inner city hospital with community-acquired pneumonia in hospitalized patients with differing immunologic status, finding that concurrent problems associated with immunosuppression were noted in 221 patients.
Journal ArticleDOI

Early Mobilization of Patients Hospitalized With Community-Acquired Pneumonia

TL;DR: Like patients hospitalized with acute myocardial infarction and total knee replacements, EM of hospitalized patients with CAP reduces overall hospital length of stay and institutional resources without increasing the risk of adverse outcomes.